Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

insulet cover image
$599
Posted in: Insulin Delivery, Other Feb 26 | 2020Insulet Q4 '19 Earnings UpdatePurchase Blast
mannkind cover image
$599
Posted in: Bolus Insulin Feb 25 | 2020MannKind Q4 '19 Earnings UpdatePurchase Blast
european medicines agency cover image
$599
Posted in: Bolus Insulin, GLP-1RA, GLP-1RA + Basal, SGLT2i Feb 25 | 2020CREDENCE CHMP Opinion This Week? DAPA-HF Filed with EMA; CHMP Agenda February 24-27Purchase Blast
sanofi cover image
$599
Posted in: Basal Insulin, Bolus Insulin, Insulin Delivery Feb 21 | 2020First Look at Sanofi's Connected Insulin Pen Solutions?Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring, Insulin Delivery Feb 20 | 2020FDA Issues Final Rule on Definition of "biological product"; ATTD 2020 Key Press Releases (Feb 20)Purchase Blast
astrazeneca cover image
$599
Posted in: Dual/triple agonist, GLP-1RA, SGLT2i Feb 14 | 2020AstraZeneca Q4 '19 Earnings UpdatePurchase Blast
dexcom cover image
$599
Posted in: Glucose Monitoring Feb 13 | 2020Dexcom Q4 '19 Earnings UpdatePurchase Blast
1 60 61 62 63 64 95

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.